Cours Charles River Laboratories International, Inc. Berne S.E.
Actions
RV6
US1598641074
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- CHF | -.--% | -.--% | -.--% |
CA 2024 * | 4,22 Md 3,84 Md | CA 2025 * | 4,53 Md 4,12 Md | Capitalisation | 11,42 Md 10,38 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 406 M 369 M | Résultat net 2025 * | 513 M 466 M | VE / CA 2024 * | 3,17 x |
Dette nette 2024 * | 1,94 Md 1,77 Md | Dette nette 2025 * | 1,46 Md 1,33 Md | VE / CA 2025 * | 2,84 x |
PER 2024 * |
28
x | PER 2025 * |
22,7
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,93% |
Dernier transcript sur Charles River Laboratories International, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 01/01/76 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 25/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 01/04/89 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 01/01/03 |
Virginia Wilson
BRD | Director/Board Member | 68 | 01/10/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 25/01/11 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
LO FUNDS GLOBAL HEALTHTECH SD USD MA | Non | 0.66M USD | -7,00% | |
UBAM BELL GLOBAL SMID CAP EQUITY IC USD | Non | 2.97M USD | +5,00% | |
NSF SICAV CONVERGENCE TECH I USD ACC | Non | 1.08M USD | +15,00% |
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+39,30% | 50,93 Md | |
-0,24% | 42,12 Md | |
+49,62% | 42,05 Md | |
-7,20% | 29,18 Md | |
+13,03% | 26,02 Md | |
-22,32% | 18,9 Md | |
+8,66% | 13,21 Md | |
+24,56% | 12,17 Md | |
+29,10% | 12,16 Md |
- Bourse
- Actions
- Action CRL
- Action RV6